Zepbound (Tirzepatide): Availability, Pricing & How to Find It in Stock

What Is Zepbound?

Zepbound is a prescription injectable medication made by Eli Lilly and Company. Its active ingredient is tirzepatide — a first-of-its-kind molecule that works on two separate hormone receptors simultaneously. The FDA approved Zepbound in November 2023 specifically for chronic weight management in adults, making it one of the newest and most talked-about medications in the obesity treatment space. It belongs to a class of drugs called GIP/GLP-1 receptor agonists, which means it mimics two naturally occurring gut hormones that regulate appetite, blood sugar, and digestion.

Zepbound is FDA-approved for adults with a body mass index (BMI) of 30 or higher — or adults with a BMI of 27 or higher who also have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. The sleep apnea indication was added in 2024, making Zepbound the first medication ever approved specifically for obesity-related sleep apnea. It is not a stimulant, not a controlled substance, and not a crash diet in a syringe — it works with your body's own hormonal systems to reduce hunger and improve metabolic function. It's worth noting that tirzepatide is also sold under the brand name Mounjaro, which carries FDA approval for type 2 diabetes management; Zepbound and Mounjaro contain the same active ingredient but are approved for different indications. There is currently no FDA-approved generic version of Zepbound available, and given Eli Lilly's patent protections, a true generic is not expected for many years.

Because Zepbound is a brand-name biologic with no generic equivalent, every patient filling this prescription is competing for the same limited supply — and that supply has struggled to keep pace with skyrocketing demand since the drug's launch. If you're having trouble finding Zepbound, FindUrMeds can locate it at a pharmacy near you.

How Does Zepbound Work?

Zepbound's active ingredient, tirzepatide, is what's called a dual agonist — it activates two gut hormone receptors at once: the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. You've probably heard of GLP-1 agonists through drugs like Ozempic or Wegovy. GIP activation is what sets tirzepatide apart. When both receptors are engaged simultaneously, the result is a stronger, more sustained appetite-suppressing effect than GLP-1 activation alone. In plain terms: your brain receives stronger and longer "I'm full" signals after eating, your stomach empties more slowly, and your body becomes more efficient at processing blood sugar. Clinical trials showed participants lost an average of 20.9% of their body weight over 72 weeks at the highest dose — a result that had never been achieved by a weight-loss medication before Zepbound.

Zepbound is administered as a once-weekly subcutaneous injection, meaning you inject it just under the skin — typically in the abdomen, thigh, or upper arm. It comes in a pre-filled auto-injector pen, so no mixing, no needles to load. Most patients begin to notice reduced appetite within the first 1 to 4 weeks of starting treatment, though measurable weight loss typically becomes apparent by weeks 4 to 8. The medication reaches steady-state concentration in the bloodstream after approximately 4 to 6 weeks of once-weekly dosing, and its half-life is about 5 days — meaning it stays active in your system throughout the entire week between injections. Your doctor will typically start you at a low dose and increase it gradually over several months to reduce side effects and allow your body to adjust.

Available Doses of Zepbound

Zepbound is available in six FDA-approved strengths, all administered once weekly by subcutaneous injection:

2.5 mg/0.5 mL — The standard starting dose for all patients. Most prescriptions begin here for the first 4 weeks.
5 mg/0.5 mL — First maintenance dose, typically reached after 4 weeks on 2.5 mg.
7.5 mg/0.5 mL — Intermediate dose, reached after 4 weeks on 5 mg.
10 mg/0.5 mL — Mid-range maintenance dose.
12.5 mg/0.5 mL — Higher maintenance dose.
15 mg/0.5 mL — The maximum approved dose; associated with the greatest average weight loss in clinical trials.

All doses are available as single-dose auto-injector pens. Your doctor will determine your target dose and titration schedule based on your response to the medication and how well you tolerate side effects. The 2.5 mg starting dose is not a therapeutic weight-loss dose on its own — it's a ramp-up dose to prepare your body for higher doses. Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

Zepbound Findability Score

Zepbound Findability Score: 18 out of 100

Our Findability Score is a proprietary metric we calculate using real-time pharmacy search data across our network of 15,000+ locations. The score runs from 1 to 100 — a score of 100 means a drug is widely stocked at nearly every pharmacy, like generic lisinopril or amoxicillin. A score of 18 means you're dealing with one of the harder-to-fill prescriptions in the country right now. Zepbound falls into that bottom tier, and unfortunately that's not a surprise given what we know about the supply chain dynamics behind this medication.

Several concrete factors drive Zepbound's low Findability Score. First, demand has vastly outpaced supply since the drug launched in late 2023 — Eli Lilly has been scaling up manufacturing capacity, but the surge in prescriptions has consistently outrun their output. According to our data across more than 340,000 pharmacy searches, tirzepatide products (both Zepbound and Mounjaro combined) rank among the top 5 most-searched medications on our platform. Second, because Zepbound is a temperature-sensitive biologic that requires cold-chain storage, not every pharmacy stocks every dose — many smaller independent pharmacies skip it entirely due to carrying costs and shelf-life constraints. Third, Eli Lilly allocates supply regionally, which means a pharmacy in one zip code may have 10 mg pens in stock while a pharmacy 3 miles away has none. Based on ASHP Drug Shortage Database records and our own platform data, tirzepatide availability has been inconsistently classified as either a formal shortage or a high-demand supply constraint since mid-2023, creating a whipsaw effect for patients who fill monthly.

What this means practically: patients trying to fill Zepbound on their own contact an average of 7–12 pharmacies before finding their dose in stock. Our Pharmacy Call Index for Zepbound — which measures the average number of calls our team makes before locating a fill — currently sits at 9.4, one of the highest of any non-controlled medication on our platform. Dose-specific scarcity is also a real problem: the 2.5 mg starter dose and 5 mg titration dose tend to be the most depleted because every new patient starts there, creating a perpetual bottleneck at the bottom of the dosing ladder.

Our success rate for locating Zepbound across all doses is 89% within 48 hours, based on our platform's analysis of Zepbound availability across all completed searches in the past 6 months. For patients in major metro areas (New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia), that rate climbs to 93%. Rural patients may see slightly longer search times, but our network extends to Walmart, Kroger, and Sam's Club pharmacy locations that urban patients often overlook. Skip the pharmacy calls. FindUrMeds finds Zepbound for you.

Zepbound Pricing

Zepbound is an expensive medication by almost any measure, and pricing varies meaningfully depending on your insurance status, the pharmacy you use, and your location.

With Insurance: Patients with commercial insurance who have Zepbound covered on their formulary typically pay a copay in the range of $25–$75 per month, depending on their plan's tier structure. However, coverage is far from universal — many insurance plans still classify Zepbound as a "lifestyle drug" or exclude obesity medications outright. Medicare Part D does not currently cover Zepbound for weight loss (though coverage for the sleep apnea indication is evolving). Always verify your specific coverage before assuming you're covered.

Without Insurance (Cash Price): The list price for Zepbound is approximately $1,059 to $1,086 per month for a four-pen supply (one injection per week). This price is consistent across doses since each pen is priced the same regardless of strength. That said, cash-pay patients have options — see below.

GoodRx Estimated Price: GoodRx discounts on Zepbound vary by pharmacy and region, but patients using GoodRx coupons typically pay approximately $900–$1,050 per month at major chain pharmacies. GoodRx savings on branded biologics like Zepbound are more limited than they are for generics, but the discount can still be meaningful depending on the pharmacy.

Eli Lilly's Savings Programs: Eli Lilly offers a savings card for commercially insured patients — eligible patients may pay as little as $25 per month (as of the most recent program terms; eligibility and terms can change, so visit Lilly's official site to confirm current offers). Lilly also offers a direct-to-patient vial program in select states at a significantly reduced price point (approximately $349–$499 per month) for self-pay patients who qualify — this program bypasses the auto-injector pen format and uses vials instead. For uninsured or underinsured patients who don't qualify for savings cards, the Lilly Cares Foundation patient assistance program may provide medication at low or no cost to eligible patients. Income limits and enrollment requirements apply.

Regional Price Variability: Prices can vary by $50–$150 per month across pharmacies in the same city, so it's worth comparing before filling. Costco and Sam's Club pharmacies sometimes offer lower cash prices than traditional chains. Price variability by region is also real — patients in the Southeast and Midwest tend to report slightly lower cash prices than those in major coastal metros.

Who Can Prescribe Zepbound?

Zepbound does not require a specialist prescription — a wide range of licensed providers can prescribe it. Here's who can write you a prescription:

Primary Care Physicians (MD, DO) — The most common prescribers. PCPs are increasingly comfortable prescribing Zepbound as obesity treatment guidelines have evolved.
Internal Medicine Specialists — Often the first point of contact for patients with metabolic conditions like type 2 diabetes, hypertension, or high cholesterol who may benefit from Zepbound.
Endocrinologists — Specialists in hormonal and metabolic disorders; frequently prescribe tirzepatide products.
Bariatric Physicians and Obesity Medicine Specialists — Board-certified obesity medicine specialists (through the American Board of Obesity Medicine) are among the highest-volume Zepbound prescribers.
Cardiologists — May prescribe Zepbound for patients with cardiovascular risk factors, particularly given emerging cardiovascular outcome data.
Nurse Practitioners (NP) and Physician Assistants (PA) — Permitted to prescribe Zepbound in all 50 states, subject to state-specific practice laws.
Telemedicine Providers — This is an important and growing category. Following COVID-era telehealth flexibilities, prescribing Zepbound via telemedicine is legal in all 50 states as of 2024. Platforms like Hims, Ro, and Found specialize in GLP-1 prescribing. Note: legitimate telemedicine prescribers will conduct a clinical intake, review your health history, and often require recent lab work — be cautious of services that prescribe without any clinical evaluation.

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.

Zepbound Side Effects

Side effects are common with Zepbound, especially during the first few months while your body adjusts to the medication. Most are related to how the drug slows your digestive system. Here's what to expect.

Most Common Side Effects

These occur in more than 5% of patients in clinical trials and are generally manageable:

Nausea — The most frequently reported side effect, especially during dose increases. Eating smaller meals and avoiding high-fat foods helps significantly.
Diarrhea — Often occurs in the first few weeks at a new dose.
Constipation — Can alternate with diarrhea; staying well hydrated and increasing fiber intake helps.
Vomiting — Less common than nausea but reported, particularly in the early titration period.
Decreased appetite — Expected and intended, but can occasionally become excessive; monitor your food intake to ensure adequate nutrition.
Stomach pain or discomfort — Often described as a general feeling of fullness or bloating.
Injection site reactions — Redness, itching, or mild bruising at the injection site. Rotating injection sites minimizes this.
Fatigue — Reported by some patients, particularly shortly after injection day.
Belching or indigestion (GERD) — Some patients notice increased reflux, especially if they have a prior history of GERD.

Less Common but Serious Side Effects

These are less common but require prompt medical attention. Contact your provider if you experience any of the following:

Pancreatitis — Severe, persistent abdominal pain that may radiate to the back, with or without vomiting. Seek emergency care.
Gallbladder problems (cholecystitis, gallstones) — Rapid weight loss increases gallstone risk. Symptoms include right upper abdominal pain, fever, and nausea.
Hypoglycemia — Most likely if you are also taking insulin or a sulfonylurea (e.g., glipizide). Know the signs: shakiness, sweating, confusion, rapid heartbeat.
Severe allergic reactions — Rash, swelling of the face or throat, difficulty breathing. Call 911.
Thyroid tumors — Tirzepatide caused thyroid C-cell tumors in animal studies. Zepbound carries a black box warning. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report any neck lump, hoarseness, or difficulty swallowing immediately.
Acute kidney injury — Usually secondary to severe dehydration from vomiting or diarrhea. Stay hydrated.
Diabetic retinopathy complications — Reported in patients with pre-existing diabetic eye disease; discuss this risk with your provider.
Heart rate increase — Some patients notice a higher resting heart rate on tirzepatide. Report sustained elevation to your provider.
Suicidal ideation — The FDA has been monitoring GLP-1 class medications for potential neuropsychiatric effects; current evidence does not confirm causality, but report any changes in mood or thoughts of self-harm immediately.

Side Effects That Typically Improve Over Time

The good news: the vast majority of GI side effects — nausea, diarrhea, constipation, and vomiting — are most intense during the first 4–8 weeks at a new dose and tend to diminish significantly as your body adjusts. Patients using FindUrMeds report that by the time they reach their maintenance dose, most describe GI side effects as "mild" or "manageable." Eating smaller, lower-fat meals, staying well hydrated, and injecting on a consistent day each week all help reduce side effect burden.

This information is for general reference only. Every patient's experience is different. Talk to your doctor or pharmacist about how to manage specific side effects, and never stop or change your medication without consulting your provider first.

Alternatives to Zepbound

Not everyone can access Zepbound — whether because of supply shortages, insurance coverage gaps, or individual medical factors. Here are the main alternatives your doctor might discuss with you.

Same-Class Alternatives

These medications work on the same or overlapping hormone pathways:

Wegovy (semaglutide 2.4 mg) — A once-weekly GLP-1 receptor agonist from Novo Nordisk, FDA-approved specifically for weight management. Head-to-head trials (SURMOUNT-5) showed tirzepatide produced greater weight loss on average, but Wegovy is a highly effective option and may be easier to find in some regions. Wegovy also has FDA-approved cardiovascular risk reduction data.
Ozempic (semaglutide 0.5–2 mg) — FDA-approved for type 2 diabetes, not weight loss, but frequently prescribed off-label for obesity. Same active ingredient as Wegovy, different dosing and indication.
Mounjaro (tirzepatide 2.5–15 mg) — Zepbound and Mounjaro contain the exact same active ingredient (tirzepatide) at the same doses, but Mounjaro is FDA-approved for type 2 diabetes. If your doctor prescribes Mounjaro and your insurance covers diabetes medications more readily than obesity medications, this can sometimes be a coverage workaround — but only if you have type 2 diabetes. Never use a medication for an indication it wasn't prescribed for without your doctor's knowledge.
Saxenda (liraglutide 3 mg) — An older once-daily injectable GLP-1 agonist approved for chronic weight management. Less effective than Zepbound on average (approximately 5–8% weight loss vs. 15–21% for tirzepatide at max dose), but may be covered by insurance plans that don't yet cover Zepbound.

Different-Mechanism Alternatives

For patients who need a non-injectable or different-class option:

Qsymia (phentermine/topiramate extended-release) — An oral combination pill that reduces appetite through central nervous system mechanisms. Controlled substance. Effective for some patients, with approximately 7–10% average weight loss.
Contrave (naltrexone/bupropion) — An oral pill that targets reward pathways to reduce cravings. Modest weight loss (approximately 5–8%) but widely available and usually less expensive.
Orlistat (Xenical / Alli) — Works by blocking fat absorption in the gut rather than appetite. Oral, available OTC at lower doses. GI side effects can be significant. Modest efficacy.
Bariatric surgery — For patients with BMI ≥40, or ≥35 with serious comorbidities, surgical options like gastric sleeve or Roux-en-Y gastric bypass remain the most effective long-term intervention for severe obesity.

If you'd prefer to stick with Zepbound, FindUrMeds has a high success rate finding it in stock.

Drug Interactions with Zepbound

Zepbound does not interact with as many medications as some other drug classes, but there are important interactions to know about. Always give your pharmacist and all of your prescribers a full list of your medications.

Serious Interactions

Insulin (all types) — Combining Zepbound with insulin significantly increases the risk of hypoglycemia (dangerously low blood sugar). Your doctor will likely reduce your insulin dose when starting tirzepatide. Blood sugar monitoring becomes more important during this transition.
Sulfonylureas (glipizide, glimepiride, glyburide) — Similar hypoglycemia risk as insulin. Dose reduction of the sulfonylurea is often required.
Oral medications with narrow therapeutic windows — Because Zepbound slows gastric emptying, it can delay absorption of oral drugs. Medications like warfarin, certain antibiotics, levothyroxine, and immunosuppressants may have altered absorption timing. Your provider may need to monitor levels more closely or adjust timing of doses.

Moderate Interactions

Other GLP-1 or GIP/GLP-1 agonists — Combining Zepbound with Ozempic, Victoza, Trulicity, or any other GLP-1 agonist is not recommended and provides no added benefit while increasing side effect risk.
SGLT-2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) — Generally considered safe in combination, but combining glucose-lowering agents increases hypoglycemia risk and should be monitored by your provider.
Oral contraceptives — Theoretically, delayed gastric emptying could affect the absorption timing of oral hormonal contraceptives. Lilly recommends using a non-oral backup contraceptive method or switching to an alternative form of contraception — particularly during the first 4 weeks after starting Zepbound and during each dose escalation.

Food and Substance Interactions

Alcohol — Alcohol can worsen nausea, a side effect already common with Zepbound. It also lowers blood sugar, which compounds hypoglycemia risk in patients on other diabetes medications. Moderate alcohol intake should be discussed with your doctor, and heavy drinking is strongly discouraged during treatment.
High-fat foods — Not a pharmacokinetic interaction, but high-fat meals are consistently associated with worsening nausea, vomiting, and GI discomfort in patients on tirzepatide. Lower-fat, smaller-portion meals are strongly recommended during the first several months.
Caffeine — No direct pharmacokinetic interaction identified, but caffeine can worsen GI symptoms (acid reflux, loose stools) that Zepbound may already be causing. Monitor your tolerance if you're a heavy coffee or energy drink consumer.
Grapefruit — No known significant interaction with tirzepatide specifically; this is more relevant for medications metabolized by the CYP3A4 enzyme pathway. Zepbound is not metabolized by CYP3A4 in a clinically meaningful way.

How to Find Zepbound in Stock

This is the part of the page you probably came here for. Finding Zepbound is genuinely difficult right now — but it's not impossible if you know where to look and how to ask. Here's a step-by-step playbook.

1. Use FindUrMeds — The Fastest Route

FindUrMeds was built specifically for situations like this: brand-name medications with high demand, uneven supply, and patients who don't have time to spend a week calling pharmacies.

Tell us what you need. Submit your drug name, dose, and zip code through our platform. No account required. This takes about 90 seconds.
We make the calls for you. Our team contacts pharmacies across our network of 15,000+ locations — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — and specifically asks for your dose of Zepbound. According to our data across 340,000+ pharmacy searches, patients who use FindUrMeds avoid an average of 9.4 pharmacy calls they would have had to make themselves.
You get a match, usually within 24–48 hours. We notify you which pharmacy has your medication in stock. You take your prescription there and pick it up. That's it. Our platform's analysis of Zepbound availability found an 89% success rate for locating this medication within 48 hours for patients across the US.

2. Use GoodRx as a Stock Indicator

Here's a trick that many patients don't know: GoodRx only displays a price at a pharmacy if that pharmacy has recently reported inventory of the medication. If you pull up Zepbound on GoodRx.com and a specific pharmacy is showing you a price, there's a reasonable (though not guaranteed) chance they have it in stock or can order it within 1–2 days.

How to use this:

Go to GoodRx.com and search "Zepbound" plus your zip code.
Filter by your specific dose.
Note which pharmacies populate with prices — those are your first calls.
Understand the limitation: GoodRx data can lag by 24–72 hours, and a pharmacy that showed stock this morning may have filled their last pen by afternoon. Use this as a lead generator, not a guarantee.

3. Check Pharmacy Apps Directly

Major pharmacy chains have built their apps and websites to show real-time or near-real-time inventory in some cases. Here's how to get the most out of each:

CVS app / CVS.com: Search for Zepbound, set your location, and use the "Check Availability" or "Transfer Prescription" feature. CVS inventory tends to be more accurate in-app than over the phone, because phone staff sometimes check the same system you're seeing.
Walgreens app: The Walgreens app allows you to search for a medication by name and check nearby store inventory. For specialty biologics like Zepbound, availability can vary hourly. If the app shows stock at a location, call to confirm before driving there.
Walmart Pharmacy: Walmart doesn't have the most robust consumer-facing inventory tool, but their pharmacy staff tend to have direct access to their warehouse ordering system. Walmart pharmacies often receive tirzepatide shipments mid-week (Tuesday–Thursday) — calling on those days rather than Monday or Friday can improve your odds.
Costco and Sam's Club: These are underrated. Costco pharmacy members often report better Zepbound availability than traditional chains in many markets, likely because their membership model limits customer volume per location. You must be a member to fill prescriptions at Costco.

4. Call with the Generic Name — And Use This Script

Many pharmacy staff look up medications by brand name, and Zepbound may show as out of stock even when the same medication is logged in their system under tirzepatide. When calling, always use the generic name and ask this specific way:

"Hi, I'm looking for tirzepatide — the generic name for Zepbound. Do you have it in stock in any strength? I'm specifically looking for [your dose], but I'd love to know what you have available."

Why this works:

Some systems catalog Eli Lilly products under tirzepatide rather than the brand name.
Asking about "any strength" helps you understand if they have a partial supply — your doctor may be able to temporarily adjust your dose if your target strength is unavailable.
Being flexible about strength (with your doctor's approval) meaningfully increases your odds of finding a fill, since different doses have different availability patterns week to week.

A few additional tips when calling:

Call Tuesday through Thursday. Many pharmacy shipments arrive early in the week, so mid-week calls catch freshly stocked shelves.
Ask if they can place a backorder or order one specifically for you — many pharmacies will do this for established customers.
Be polite and specific. Pharmacy staff deal with a high volume of Zepbound inquiries and are more likely to go the extra mile for patients who are kind and prepared.

Ready to stop calling pharmacies and start actually getting your medication?

Find Zepbound Near You — Let FindUrMeds Do the Work →

✅ We contact 15,000+ pharmacies on your behalf ✅ 89% success rate for Zepbound specifically ✅ Results typically within 24–48 hours ✅ Trusted by 200+ healthcare providers nationwide

Frequently Asked Questions

Is Zepbound still in shortage?

As of 2025, Zepbound is not on the FDA's official drug shortage list — Eli Lilly removed tirzepatide from the FDA shortage database in mid-2024 after significantly expanding manufacturing capacity. However, being off the official shortage list does not mean it's easy to find. Demand continues to far exceed available supply at many pharmacy locations, and patients consistently report difficulty locating specific doses. Based on our platform's analysis of Zepbound availability across all searches in the past 6 months, patients attempting to fill Zepbound on their own contact an average of 7–12 pharmacies before finding their dose. The 2.5 mg and 5 mg starter doses remain the hardest to find consistently. The practical experience for most patients still feels like a shortage — because in many communities, it effectively is one.

How much does Zepbound cost without insurance?

Without insurance, Zepbound's list price is approximately $1,059–$1,086 per month for a one-month supply (four auto-injector pens). However, self-pay patients have meaningful options to reduce this cost. Eli Lilly's savings card program can bring costs down to $25/month for eligible commercially insured patients. For uninsured patients, Lilly offers a direct-to-patient vial program in select states at approximately $349–$499 per month (this uses vials rather than auto-injector pens). The Lilly Cares Foundation patient assistance program provides free or low-cost medication to qualifying patients who meet income thresholds. GoodRx can provide modest discounts at some pharmacies, typically bringing cash price to $900–$1,050/month. It's worth contacting Lilly directly or asking your doctor's office about all available programs before paying full list price.

Can I get Zepbound through mail order?

Yes — in theory. Many insurance plans with Zepbound coverage offer 90-day mail-order fills through pharmacy benefit managers (PBMs) like Express Scripts, CVS Caremark, or OptumRx. Mail order can be convenient and sometimes cheaper (90-day supply at a lower per-month rate). However, because Zepbound is a temperature-sensitive biologic, it must be shipped with cold-chain packaging, and not all mail-order services handle this reliably in extreme weather. Some patients also find that mail-order pharmacies face the same supply constraints as brick-and-mortar locations — and because mail order typically requires more lead time, a supply disruption can leave you without medication for longer than an in-person fill would. If you go the mail-order route, order at least 2 weeks before you'll run out to account for shipping delays and potential back-order situations.

What's the difference between Zepbound and Wegovy?

Both Zepbound and Wegovy are FDA-approved for chronic weight management in adults and are once-weekly injectables, but they have meaningfully different mechanisms and clinical profiles. Zepbound's active ingredient (tirzepatide) targets two hormone receptors — GLP-1 and GIP — while Wegovy's active ingredient (semaglutide 2.4 mg) targets only GLP-1. In a head-to-head clinical trial (SURMOUNT-5, published in 2024), participants on tirzepatide lost an average of 20.2% of body weight compared to 13.7% for those on semaglutide — a difference of approximately 47% greater weight loss with tirzepatide. Wegovy, however, has a longer track record (approved in 2021 vs. 2023 for Zepbound) and has FDA-approved data specifically showing cardiovascular event reduction in high-risk patients (the SELECT trial). Availability and insurance coverage vary by region and plan — in some markets, Wegovy is actually easier to find than Zepbound, while the reverse is true in others. Your doctor is the right person to help you weigh these options based on your medical history.

What if my pharmacy is out of Zepbound?

First, don't panic — running out of Zepbound for one week is not a medical emergency in most cases, though you should let your provider know. GLP-1 and dual agonist medications leave your system gradually over several weeks, so a brief interruption is unlikely to undo your progress. Here are your immediate next steps:

Ask your pharmacy if they can backorder your dose — many chain pharmacies can request a specific medication and notify you when it arrives, typically within 3–7 days.
Ask your doctor if an adjacent dose is available — if your 10 mg is out of stock but 7.5 mg is available, your provider may authorize a temporary adjustment.
Use FindUrMeds — our team will search 15,000+ pharmacy locations for your specific dose. 89% of patients get a match within 48 hours.
Try independent pharmacies — small independent pharmacies are often overlooked but sometimes carry doses that chains are out of, because they serve a smaller patient base.
Contact Eli Lilly's patient support line — they can sometimes direct you to pharmacies in your region with confirmed stock.

Need help finding Zepbound in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Zepbound Near You →

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Zepbound

Findability Score: 14/100